Clinical Trial Update: Selective Estrogen Receptor Modulators - A Potential Treatment for Psychotic Symptoms of Schizophrenia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial exploring selective estrogen receptor modulators as a potential treatment for psychotic symptoms in schizophrenia; the study is reported …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia
• Schizophreniform Disorder

Drugs mentioned

• Selective estrogen receptor modulators

Snippet

Sponsor: The Alfred | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 4 | Status: COMPLETED